MiLaboratories

MiLaboratories

Private
San Francisco, CaliforniaHealthcare & Life Sciencesmilaboratories.com

Last Round

Series A

Oct 10, 2024

Total Funding Raised

$12.3M

Momentum Score

50 /100

Company Overview

MiLaboratories is a biotechnology company that develops medical imaging software for interactive analysis of T-cell and B-cell receptor repertoire high-throughput sequencing data, facilitating experiment planning, sample preparation, sequencing, data processing, and the extraction of clinically relevant features to aid in the identification of similarities in immunology sequencing data and the development of autoimmune disease drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Usage-Based SaaS, Hardware Sales, Marketplace Commission, Services & Consulting

AI Layer

Application

Keywords

immune repertoire profilingcomputational biology platformNGS data analysisimmunosequencingnext-generation sequencingNGSbioinformatics softwareimmunoinformaticsantibody discoveryTCR sequencing analysisBCR sequencing analysisdrug discoveryvaccine developmentcancer researchbioinformatics SDKfreemium SaaSimmunosequencing kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiLaboratories Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MiLaboratories Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AOct 10, 2024
SeedFeb 17, 2022

Key People

Founding team and executive leadership

Dmitriy Bolotin

Chief Technology Officer, Co-founder

Founding Team

Stanislav Poslavsky

Chief Executive Officer, Co-founder

Founding Team

Roberto Gomez Ledesma

COO

Executive Team

MiLaboratories Investors

Notable investors and investment history

InvestorRounds
Acrobator VenturesSeries A, Seed
KfundSeries A
AcrobatorSeries A
Courtyard VenturesSeries A
EGB CapitalSeries A
SpeedinvestSeries A, Seed
Somersault VenturesSeries A

MiLaboratories Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MiLaboratories Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiLaboratories's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range23
Year Founded2021
Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.